About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Discover New Trigger for Epidemic of Metabolic Syndrome

by Kathy Jones on February 26, 2012 at 11:01 PM
Font : A-A+

 Scientists Discover New Trigger for Epidemic of Metabolic Syndrome

A key suspect in the destructive inflammation that underlies heart disease and diabetes has been uncovered in a new study led by an Indian-origin scientist.

The research shows elevated levels of a receptor present on leucocytes of the innate immune response in people at risk for these chronic diseases. The receptors are the body's first line of defense against infectious invaders, and they trigger a rush of cytokines, the body's aggressive immune soldiers, into the bloodstream.

Advertisement

Diabetes expert Ishwarlal Jialal and his team at the UC Davis Medical Center studied individuals diagnosed with metabolic syndrome - a cluster of cardio-metabolic risk factors linked to many life-threatening diseases.

The syndrome is a high-risk obesity state as previously shown by Jialal's team. It increases the risk of developing diabetes at least five-fold and heart disease by two- to four-fold.
Advertisement

The receptors, or sensors, on cells are called Toll-like receptors (TLRs), and the Nobel Prize was awarded last year for discoveries that showed they initiate the swift innate immune response to infections. But the inflammation they trigger can also be harmful. In mice it has been shown that two TLRs-TLR2 AND TLR4 -- are important in the development of both diabetes and heart disease.

These receptors are present in many cells, but they are most abundant on monocytes, a type of white blood cell that plays a central role in the inflammation response to invading microbes. They can be triggered by pathogen products or signals from dying cells and saturated fatty acid.

The UC Davis research focused on TLR2 and TLR4. For the study, researchers evaluated 90 individuals between the ages of 21 and 70, of whom 49 had at least three features characteristic of metabolic syndrome.

These included hypertension, low HDL-cholesterol, high triglycerides and obesity, as evidenced by increased waist circumference, or a glucose level between 101-125 mg/dl but not indicative of diabetes. Members of the control group had no more than two such markers.

Comparisons of the blood of participants from both groups showed that the metabolic syndrome group exhibited significantly higher levels of both messenger RNA and cell-surface receptor proteins TLR2 and TLR4, increased levels of the master switch of inflammation in the nucleus, and a much higher concentration of immune soldiers in the blood, such as cytokines, that create inflammation.

All of these abnormalities were independent of obesity, suggesting they are due to the metabolic-syndrome environment. The levels of both free fatty acids and the product of gram-negative bacteria endotoxin also were increased in the blood of individuals with metabolic syndrome at least two- and three-fold respectively, and explained in part the TLR4 increase.

The research suggests that suppressing TLR activity with weight loss and with diet, exercise and drugs targeted specifically at these receptors, might prove effective in treating heart disease, diabetes and other conditions linked to metabolic syndrome.

Jialal, professor of pathology and laboratory medicine at UC Davis Health System, pointed out that not all obese people suffer from the constellation of symptoms that make up metabolic syndrome, and in fact, about 30 percent of obese people are at low risk for metabolic complications, according to one key study.

But since research shows increased inflammation in obese people, the Toll-like receptor and monocyte findings may help define individuals at high risk for obesity.

Jialal's research group reported last year that monocytes and related macrophages were present in the fat of individuals with metabolic syndrome and that their fat was more inflamed.

The new finding shows that the Toll-like sentinel proteins might be directing an increase in this activity, and that the inflammatory agents are making it into the bloodstream, from where they can go to any part of the body, including fat, liver and heart.

The latest study was published in the journal Diabetes Care on Feb. 22.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Metabolic Syndrome Syndrome X 

Recommended Reading
Metabolic Defects
Metabolism is the sum total of all chemical and physical changes that take place in any organism ......
Battle of the Bulge
The 'battle of bulge' is the toughest of all battles. Once you put on weight it is so difficult to ....
Diabetic Diet Insulin : Sugar and Foodá
Encyclopedia section of medindia briefly explains about Insulin - Sugar and Food...
Metabolic Syndrome
Metabolic Syndrome is associated with sedentary lifestyle .It makes a person more prone to develo...
Syndrome X
"Syndrome X" or "Metabolic syndrome" is a group of conditions that puts a person at risk for diabete...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)